Healthcare / Health Information ServicesNasdaqCM
$0.05
-0.03 (-37.31%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-785507.00 · quality 49.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
15/100
F
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$188496
P/E
N/A
•EV/EBITDA
N/A
•ROE
-33.9%
↓Gross Margin
45.0%
↓Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-7.0%
FCF CAGR
—
FCF margin
6.1%
FCF / Net income
-0.11x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $11.4M · net income $-6.3M · FCF $692830.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.4M | $11.4M | $15.9M | $19.4M | $14.2M |
| Net Income | $-6.3M | $-6.3M | $-643229.00 | $-11.3M | $-2.9M |
| EBITDA | $-5.9M | $-5.9M | $87088.00 | $-4.5M | $-2.2M |
| EPS | — | — | -0.99 | -34.83 | -9.05 |
| Gross Margin | 45.0% | 45.0% | 56.2% | 43.8% | 44.9% |
| Operating Margin | -54.4% | -54.4% | -2.2% | -27.8% | -20.9% |
| Net Margin | -55.5% | -55.5% | -4.1% | -58.3% | -20.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.04 | 0.06 |
| Current Ratio | 11.11 | 11.11 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $692830.00 | $692830.00 | $-4.5M | $-785507.00 | $-2.5M |
| Returns | |||||
| ROE | -33.9% | -33.9% | -3.1% | -63.0% | -9.8% |
| Valuation | |||||
| EV/EBITDA | — | — | 14.03 | — | — |
| P/B | 0.01 | 0.01 | 0.43 | 0.51 | 1.03 |
| Growth & Yield | |||||
| Revenue Growth | -28.3% | -28.3% | -18.4% | 37.3% | — |
| EPS Growth | — | — | 97.2% | -284.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-99.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.99 → n/d
Residual
-99.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.